University of Washington, Department of Biochemistry, Institute for Protein Design, Seattle, WA, USA.
Knight Campus Center, University of Oregon, Eugene, OR, USA.
Nat Commun. 2021 Jun 7;12(1):3384. doi: 10.1038/s41467-021-23609-8.
Despite recent success in computational design of structured cyclic peptides, de novo design of cyclic peptides that bind to any protein functional site remains difficult. To address this challenge, we develop a computational "anchor extension" methodology for targeting protein interfaces by extending a peptide chain around a non-canonical amino acid residue anchor. To test our approach using a well characterized model system, we design cyclic peptides that inhibit histone deacetylases 2 and 6 (HDAC2 and HDAC6) with enhanced potency compared to the original anchor (IC values of 9.1 and 4.4 nM for the best binders compared to 5.4 and 0.6 µM for the anchor, respectively). The HDAC6 inhibitor is among the most potent reported so far. These results highlight the potential for de novo design of high-affinity protein-peptide interfaces, as well as the challenges that remain.
尽管最近在结构环肽的计算设计方面取得了成功,但设计能够结合任何蛋白质功能位点的新型环肽仍然具有挑战性。为了解决这一挑战,我们开发了一种计算“锚定延伸”方法,通过围绕非规范氨基酸残基锚定点延伸肽链来靶向蛋白质界面。为了使用经过充分表征的模型系统测试我们的方法,我们设计了与原始锚定物相比具有增强效力的环肽来抑制组蛋白去乙酰化酶 2 和 6(HDAC2 和 HDAC6)(最佳结合物的 IC 值分别为 9.1 和 4.4 nM,而锚定物的 IC 值分别为 5.4 和 0.6 µM)。该 HDAC6 抑制剂是迄今为止报道的最有效的抑制剂之一。这些结果突出了从头设计高亲和力蛋白质-肽界面的潜力,以及仍然存在的挑战。